Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

1789703-37-2Vildagliptin Imine Impurity

● Auf Lager

Katalog-Nr.::	VE006421
CAS-Nr.::	1789703-37-2
Summenformel::	C17H25N3O2
Molare Masse::	303.4

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 1789703-37-2

Parent drug

Vildagliptin

IUPAC-Name

2-((1r,3s,5R,7S)-3-hydroxyadamantan-1-yl)-1-iminohexahydropyrrolo[1,2-a]pyrazin-4(1H)-one

Pharmakopöe-Synonyme

N/A

Other Synonyms

Vildagliptin Cyclo Imidamide; Vildagliptin Impurity A; 2-(3-Hydroxyadamantan-1-yl)-1-iminohexahydropyrrolo[1,2-a]pyrazin-4(1H)-one; Vildagliptin Mono Keto Impurity

Smile

O=C1CN([C@]23C[C@]4(O)C[C@](C3)([H])C[C@@](C4)([H])C2)C(C5N1CCC5)=N

InChI

InChI=1S/C17H25N3O2/c18-15-13-2-1-3-19(13)14(21)9-20(15)16-5-11-4-12(6-16)8-17(22,7-11)10-16/h11-13,18,22H,1-10H2/t11-,12+,13?,16+,17+

Beschreibung

Vildagliptin Imine Impurity is a well-characterized reference material that meets stringent regulatory standards set by USP, EMA, JP, and BP. It plays a key role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Vildagliptin. It is an orally-active antihyperglycemic agent that manages type II diabetes mellitus by inhibiting the DD4 enzyme.

References

By K.M. Prasanna Kumar, U. Phadke, H. Brath, A. Gawai, P.M. PaldÃ¡nius, C. Mathieu Container: Primary Care Diabetes Year: 2016 Volume: 10 Issue: 6 DOI: 10.1016/j.pcd.2016.06.001 URL: https://www.sciencedirect.com/science/article/pii/S1751991816300432